Europe Crispr Market Forecast 2021-2028

Europe Crispr Market Forecast 2021-2028


The Europe CRISPR market is evaluated to register a CAGR of 20.39% during the projected period of 2021 to 2028. Leading factors like increased innovations in CRISPR technologies as well as the development of risk assessment guidelines by the European Food Safety Authority (EFSA) for genetically modified animals and plants are set to propel the market growth of the region.


The Europe CRISPR market growth assessment entails the in-depth study of Germany, France, Switzerland, Italy, Russia, the United Kingdom, the Netherlands, and the rest of Europe. Research groups in Switzerland are primarily responsible for the growth of the country’s CRISPR market. For instance, in 2019, a research group at ETH Zurich, Switzerland, proposed to overcome the limitation of CRISPR in creating cell therapies, with a CRISPR technique capable of editing 25 genes in one go. Besides, this number could also be increased to up to hundreds of genes at once. As a result, the method makes it possible to edit gene networks as well as reprogram stem cells to become cell therapies including insulin-producing pancreatic cells or skin cells.

On the other hand, in Russia, geneticists and biologists are prepared to experiment with CRISPR gene editing techniques for editing human embryos. In 2019, for instance, Russian biologist Denis Rebrikov commenced gene editing in eggs donated by women who can hear in order to learn how deaf couples could birth children without a genetic mutation responsible for impaired hearing. Hence, these factors are anticipated to fuel the CRISPR market growth in Europe.


Distinguished companies operating in the market are CRISPR Therapeutics AG, Cellectis Bioresearch SAS, Horizon Discovery Group, etc.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Risk Of Congenital Anomalies
3.1.2. Prevalence Of Genetic Disorders
3.1.3. Growing Use Of Crispr In Agriculture
3.1.4. Rising Awareness Regarding Gene Therapeutics
3.2. Key Restraints
3.2.1. Possible Misuse Of Crispr Gene-editing Tool
3.2.2. Lack Of Healthcare Budgets In Developing Countries
3.2.3. Ethical Issues
4. Key Analytics
4.1. Impact Of Covid-19 On Crispr Market
4.2. Patent Analysis
4.3. Funding Scenario
4.4. Key Market Trends
4.5. Porter's Five Forces Analysis
4.5.1. Buyers Power
4.5.2. Suppliers Power
4.5.3. Substitution
4.5.4. New Entrants
4.5.5. Industry Rivalry
4.6. Opportunity Matrix
4.7. Vendor Landscape
4.8. Key Buying Criteria
4.8.1. Cost
4.8.2. Accuracy
4.8.3. Easy To Use
4.9. Legal & Regulatory Framework
5. Market By Product
5.1. Plasmids
5.2. Vectors
5.3. Proteins
5.4. Designing Tools
5.5. Grna
5.6. Control Kits
5.7. Library
5.8. Other Products
6. Market By Application
6.1. Genome Editing/Genetic Engineering
6.2. Crispr Plasmid
6.3. Human Stem Cells
6.4. Grna Database/Gene Library
6.5. Cell Line Engineering
7. Market By End-user
7.1. Therapeutics And Drug Discovery
7.2. Biological Research
7.3. Agricultural Biotech
7.4. Industrial Biotech
8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis United Kingdom Germany France Italy Russia Netherlands Switzerland Rest Of Europe
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Addgene
9.2.2. Caribou Biosciences Inc
9.2.3. Cellectis Bioresearch Sas
9.2.4. Crispr Therapeutics Ag
9.2.5. Editas Medicine
9.2.6. Genscript
9.2.7. Horizon Discovery Group
9.2.8. Integrated Dna Technologies
9.2.9. Intellia Therapeutics
9.2.10. Lonza Group Ltd
9.2.11. New England Biolabs
9.2.12. Novartis International Ag
9.2.13. Origene Technologies Inc
9.2.14. Precision Biosciences
9.2.15. Synthego Corporation
9.2.16. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings